Diabetic Shoes: Global Strategic Business Report

Global Diabetic Shoes Market to Reach $15.2 Billion by 2030

The global market for Diabetic Shoes estimated at US$8.2 Billion in the year 2022, is projected to reach a revised size of US$15.2 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2022-2030. Online, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$10.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Offline segment is readjusted to a revised 7.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 13.2% CAGR

The Diabetic Shoes market in the U.S. is estimated at US$2.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 7.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Select Competitors (Total 42 Featured) -

• Advanced Diabetic Solutions
• Aetrex Worldwide, Inc.
• Apex Foot Health Industries, LLC
• DARCO International, Inc.
• Dr. Comfort LLC
• Dr. Zen, Inc.
• Drew Shoe Corporation
• Etonic Worldwide LLC
• Orthofeet, Inc.
• Podartis Srl

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and the publisher's Research Platform
• Complimentary updates for one year